Literature DB >> 14512557

General strategy for broadening adenovirus tropism.

Laura Fontana1, Maurizio Nuzzo, Lorena Urbanelli, Paolo Monaci.   

Abstract

In spite of its broad host range, adenovirus type 5 (Ad5) transduces a number of clinically relevant tissues and cell types inefficiently, mostly because of low expression of the coxsackievirus-adenovirus receptor (CAR). To improve gene transfer to such cells, we modified the Ad5 fiber knob to recognize novel receptors. We expressed a functional Ad5 fiber knob domain on the capsid of phage lambda and employed this display system to construct a large collection of ligands in the HI loop of the Ad5 knob. Panning this library on the CAR-negative mouse fibroblast cell line NIH 3T3 resulted in the identification of three clones with increased binding to these cells. Adenoviruses incorporating these ligands in the fiber gene transduced NIH 3T3 cells 2 or 3 orders of magnitude better than the parent vector. The same nonnative tropism was revealed in other cell types, independently of CAR expression. These Ad5 derivatives proved capable of transducing mouse and human primary immature dendritic cells with up to 100-fold increased efficiency.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14512557      PMCID: PMC225005          DOI: 10.1128/jvi.77.20.11094-11104.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells.

Authors:  L Zhong; A Granelli-Piperno; Y Choi; R M Steinman
Journal:  Eur J Immunol       Date:  1999-03       Impact factor: 5.532

2.  CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts.

Authors:  C Hidaka; E Milano; P L Leopold; J M Bergelson; N R Hackett; R W Finberg; T J Wickham; I Kovesdi; P Roelvink; R G Crystal
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

Review 3.  Update on adenovirus and its vectors.

Authors:  W C Russell
Journal:  J Gen Virol       Date:  2000-11       Impact factor: 3.891

4.  An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.

Authors:  M B Lutz; N Kukutsch; A L Ogilvie; S Rössner; F Koch; N Romani; G Schuler
Journal:  J Immunol Methods       Date:  1999-02-01       Impact factor: 2.303

5.  Phage display of adenovirus type 5 fiber knob as a tool for specific ligand selection and validation.

Authors:  A Pereboev; L Pereboeva; D T Curiel
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Immunotherapy of cancer with dendritic cell-based vaccines.

Authors:  S K Nair
Journal:  Gene Ther       Date:  1998-11       Impact factor: 5.250

7.  Polylysine modification of adenoviral fiber protein enhances muscle cell transduction.

Authors:  K Bouri; W G Feero; M M Myerburg; T J Wickham; I Kovesdi; E P Hoffman; P R Clemens
Journal:  Hum Gene Ther       Date:  1999-07-01       Impact factor: 5.695

8.  Recombinant human adenovirus: targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium.

Authors:  H Xia; B Anderson; Q Mao; B L Davidson
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

9.  Coxsackievirus-adenovirus receptor expression in ovarian cancer cell lines is associated with increased adenovirus transduction efficiency and transgene expression.

Authors:  Z You; D C Fischer; X Tong; A Hasenburg; E Aguilar-Cordova; D G Kieback
Journal:  Cancer Gene Ther       Date:  2001-03       Impact factor: 5.987

10.  Group D adenoviruses infect primary central nervous system cells more efficiently than those from group C.

Authors:  M Chillon; A Bosch; J Zabner; L Law; D Armentano; M J Welsh; B L Davidson
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more
  10 in total

1.  Selection of muscle-binding peptides from context-specific peptide-presenting phage libraries for adenoviral vector targeting.

Authors:  Debadyuti Ghosh; Michael A Barry
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 2.  Current advances and future challenges in Adenoviral vector biology and targeting.

Authors:  Samuel K Campos; Michael A Barry
Journal:  Curr Gene Ther       Date:  2007-06       Impact factor: 4.391

Review 3.  Molecular engineering of viral gene delivery vehicles.

Authors:  David V Schaffer; James T Koerber; Kwang-il Lim
Journal:  Annu Rev Biomed Eng       Date:  2008       Impact factor: 9.590

4.  Novel adenovirus vectors 'capsid-displaying' a human complement inhibitor.

Authors:  Sergey S Seregin; Zachary C Hartman; Daniel M Appledorn; Sarah Godbehere; Haixiang Jiang; Michael M Frank; Andrea Amalfitano
Journal:  J Innate Immun       Date:  2010-02-11       Impact factor: 7.349

5.  Gene transduction and cell entry pathway of fiber-modified adenovirus type 5 vectors carrying novel endocytic peptide ligands selected on human tracheal glandular cells.

Authors:  Florence Gaden; Laure Franqueville; Maria K Magnusson; Saw See Hong; Marc D Merten; Leif Lindholm; Pierre Boulanger
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 6.  Display technologies: application for the discovery of drug and gene delivery agents.

Authors:  Anna Sergeeva; Mikhail G Kolonin; Jeffrey J Molldrem; Renata Pasqualini; Wadih Arap
Journal:  Adv Drug Deliv Rev       Date:  2006-10-06       Impact factor: 15.470

7.  Adenovirus-mediated gene transfer of interleukin-4 into pancreatic stellate cells promotes interleukin-10 expression.

Authors:  Peter Brock; Gisela Sparmann; Thomas Ritter; Robert Jaster; Stefan Liebe; Jörg Emmrich
Journal:  J Cell Mol Med       Date:  2006 Oct-Dec       Impact factor: 5.310

8.  Gs-DREADD Knock-In Mice for Tissue-Specific, Temporal Stimulation of Cyclic AMP Signaling.

Authors:  Dmitry Akhmedov; Maria G Mendoza-Rodriguez; Kavitha Rajendran; Mario Rossi; Jürgen Wess; Rebecca Berdeaux
Journal:  Mol Cell Biol       Date:  2017-04-14       Impact factor: 4.272

9.  Improved Induction of Anti-Melanoma T Cells by Adenovirus-5/3 Fiber Modification to Target Human DCs.

Authors:  Dafni Chondronasiou; Tracy-Jane T H D Eisden; Anita G M Stam; Qiana L Matthews; Mert Icyuz; Erik Hooijberg; Igor Dmitriev; David T Curiel; Tanja D de Gruijl; Rieneke van de Ven
Journal:  Vaccines (Basel)       Date:  2018-07-18

10.  Lentiviral vector induces high-quality memory T cells via dendritic cells transduction.

Authors:  Min Wen Ku; Pierre Authié; Fabien Nevo; Philippe Souque; Maryline Bourgine; Marta Romano; Pierre Charneau; Laleh Majlessi
Journal:  Commun Biol       Date:  2021-06-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.